Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_51195 | 51 | 1.06 | Mlig455_020957 | Neo: - Age: Down-Down-Up |
CDK5R1 | Mlig455_020957 {REF} {Length: 1912} {Pfam: Cyclin-dependent kinase 5 activator protein [PF03261.17, score=249.3]} {Human: ENSG00000176749, CDK5R1, cyclin dependent kinase 5 regulatory subunit 1, [RH, Score=191, Expect=5e-57]} {Mouse: ENSMUSG00000048895, Cdk5r1, cyclin-dependent kinase 5, regulatory subunit 1 (p35), [RH, Score=191, Expect=4e-57]} {Dmel: FBgn0027491, Cdk5alpha, Cdk5 activator-like protein, [RH, Score=199, Expect=2e-58]} {Celegans: WBGene00011955, cdka-1, Cyclin-dependent kinase 5 activator 1, [RH, Score=176, Expect=5e-51]} {Smed: dd_Smed_v6_13788_0_1, dd_Smed_v6_13788_0_1, [RH, Score=216, Expect=9e-67]} {RNA1509_28436} {RNA1310_14097} {RNA815_13436} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.006 | 1.305 | 0.99973 | 1.00000 | |
RegionR2 | 2.189 | 1.305 | 0.13197 | 0.45089 | |
RegionR3 | -2.827 | 1.305 | 1.00000 | 1.00000 | |
RegionR4 | 1.593 | 1.305 | 0.29161 | 0.60258 | |
RegionR5 | -0.07 | 1.305 | 0.63286 | 0.98597 | |
RegionR6 | -1.254 | 1.305 | 0.87665 | 1.00000 | |
RegionR7 | -2.591 | 1.305 | 1.00000 | 1.00000 | |
RegionR8 | 2.966 | 1.305 | 0.10027 | 0.59433 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -2.08 | 1.305 | 0.99992 | 1.00000 | |
RegenerationR2 | -0.367 | 1.305 | 0.55480 | 0.89556 | |
RegenerationR3 | 2.02 | 1.305 | 0.18273 | 0.61877 | |
RegenerationR4 | -0.556 | 1.305 | 0.77916 | 0.98008 | |
RegenerationR5 | 0.296 | 1.305 | 0.78555 | 0.98343 | |
RegenerationR6 | 0.657 | 1.305 | 0.66786 | 0.90772 | |
RegenerationBL | 2.594 | 1.305 | 0.09018 | 0.35184 | |
RegenerationTP | 0.532 | 1.305 | 0.67039 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_51195 | 51 | 1.06 | Mlig455_020957 | Neo: - Age: Down-Down-Up |
CDK5R1 | 4 | - | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_020957 {REF} {Length: 1912} {Pfam: Cyclin-dependent kinase 5 activator protein [PF03261.17, score=249.3]} {Human: ENSG00000176749, CDK5R1, cyclin dependent kinase 5 regulatory subunit 1, [RH, Score=191, Expect=5e-57]} {Mouse: ENSMUSG00000048895, Cdk5r1, cyclin-dependent kinase 5, regulatory subunit 1 (p35), [RH, Score=191, Expect=4e-57]} {Dmel: FBgn0027491, Cdk5alpha, Cdk5 activator-like protein, [RH, Score=199, Expect=2e-58]} {Celegans: WBGene00011955, cdka-1, Cyclin-dependent kinase 5 activator 1, [RH, Score=176, Expect=5e-51]} {Smed: dd_Smed_v6_13788_0_1, dd_Smed_v6_13788_0_1, [RH, Score=216, Expect=9e-67]} {RNA1509_28436} {RNA1310_14097} {RNA815_13436} |
2. | MligTC455_16305 | 45 | 0.93 | Mlig455_005717 | Neo: - Age: - |
3.517 | - | - | 0.831 | 0.939 | 0.773 | 0.974 | Mlig455_005717 {REF} {Length: 1504} {Pfam: Protein of unknown function (DUF4532) [PF15046.8, score=28.1]} {RNA1310_54208} {RNA815_57875} | |
3. | MligTC455_52349 | 99 | 2.06 | Mlig455_011056 | Neo: - Age: - |
DGKI | 3.493 | - | - | 0.964 | 0.893 | 0.772 | 0.864 | Mlig455_011056 {REF} {Length: 3706} {Pfam: Diacylglycerol kinase accessory domain [PF00609.21, score=146.1]; Diacylglycerol kinase catalytic domain [PF00781.26, score=101.1]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=31.0]; Proline-rich protein family 20 [PF15708.7, score=21.0]} {Human: ENSG00000157680, DGKI, diacylglycerol kinase iota, [Score=677, Expect=0.0]; ENSG00000149091, DGKZ, diacylglycerol kinase zeta, [Score=672, Expect=0.0]} {Mouse: ENSMUSG00000038665, Dgki, diacylglycerol kinase, iota, [Score=682, Expect=0.0]; ENSMUSG00000040479, Dgkz, diacylglycerol kinase zeta, [Score=667, Expect=0.0]} {Dmel: FBgn0261549, rdgA, retinal degeneration A, [Score=533, Expect=8e-173]} {Celegans: WBGene00019428, dgk-5, Putative diacylglycerol kinase K06A1.6, [RH, Score=491, Expect=4e-158]} {Smed: dd_Smed_v6_12579_0_4, dd_Smed_v6_12579_0_4, [Score=629, Expect=0.0]} {RNA1509_51540} {RNA1310_9558, RNA1509_51540} {RNA1509_51540, RNA815_11195} |
4. | MligTC455_49663 | 245 | 5.1 | Mlig455_013565 | Neo: - Age: - |
CDH23 | 3.383 | - | - | 0.738 | 0.950 | 0.840 | 0.855 | Mlig455_013565 {REF} {Length: 7289} {Pfam: Cadherin domain [PF00028.19, score=361.2]; Cadherin-like [PF08266.14, score=38.9]} {Human: ENSG00000107736, CDH23, cadherin related 23, [Score=372, Expect=1e-103]} {Mouse: ENSMUSG00000012819, Cdh23, cadherin 23 (otocadherin), [Score=375, Expect=6e-105]} {Dmel: FBgn0038247, Cad88C, Cadherin 88C, [Score=362, Expect=2e-101]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=224, Expect=2e-58]} {Smed: dd_Smed_v6_15356_0_1, dd_Smed_v6_15356_0_1, [Score=414, Expect=3e-118]} {RNA1509_16482} {RNA1310_682} {RNA815_249} |
5. | MligTC455_51194 | 408 | 8.5 | Mlig455_007624, Mlig455_007645 | Neo: - Age: - Region-specific R2: 3.993 Region-enriched R2: 3.717/0.00015 |
CDK5R1 | 3.225 | - | - | 0.820 | 0.976 | 0.719 | 0.710 | Mlig455_007624 {REF} {Length: 1990} {Pfam: Cyclin-dependent kinase 5 activator protein [PF03261.17, score=249.2]} {Human: ENSG00000176749, CDK5R1, cyclin dependent kinase 5 regulatory subunit 1, [RH, Score=191, Expect=7e-57]} {Mouse: ENSMUSG00000048895, Cdk5r1, cyclin-dependent kinase 5, regulatory subunit 1 (p35), [RH, Score=191, Expect=6e-57]} {Dmel: FBgn0027491, Cdk5alpha, Cdk5 activator-like protein, [RH, Score=199, Expect=2e-58]} {Celegans: WBGene00011955, cdka-1, Cyclin-dependent kinase 5 activator 1, [RH, Score=176, Expect=6e-51]} {Smed: dd_Smed_v6_13788_0_1, dd_Smed_v6_13788_0_1, [RH, Score=215, Expect=1e-66]} {RNA1509_28436} {RNA1310_14097} {RNA815_13436} Mlig455_007645 {REF} {Length: 1937} {Pfam: Cyclin-dependent kinase 5 activator protein [PF03261.17, score=249.3]} {Human: ENSG00000176749, CDK5R1, cyclin dependent kinase 5 regulatory subunit 1, [RH, Score=191, Expect=8e-57]} {Mouse: ENSMUSG00000048895, Cdk5r1, cyclin-dependent kinase 5, regulatory subunit 1 (p35), [RH, Score=191, Expect=5e-57]} {Dmel: FBgn0027491, Cdk5alpha, Cdk5 activator-like protein, [RH, Score=199, Expect=3e-58]} {Celegans: WBGene00011955, cdka-1, Cyclin-dependent kinase 5 activator 1, [RH, Score=177, Expect=2e-51]} {Smed: dd_Smed_v6_13788_0_1, dd_Smed_v6_13788_0_1, [RH, Score=216, Expect=1e-66]} {RNA1509_28436} {RNA1310_14097} {RNA815_13436} |
6. | MligTC455_27591 | 24 | 0.5 | Mlig455_021100 | Neo: - Age: - |
2.888 | - | - | 0.993 | 0.957 | - | 0.938 | Mlig455_021100 {REF} {Length: 1478} {RNA1509_46103} {RNA1310_81900} {RNA815_8813.1} | |
7. | MligTC455_48656 | 24 | 0.5 | Mlig455_039647 | Neo: - Age: - |
2.852 | - | - | 0.993 | 0.948 | 0.911 | - | Mlig455_039647 {REF} {Length: 1715} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.7]} {RNA1310_48037} {RNA815_27969} | |
8. | MligTC455_17579 | 76 | 1.58 | Mlig455_042836, Mlig455_045854, Mlig455_045870 | Neo: - Age: - |
RNF217 | 2.849 | - | - | 0.984 | 0.965 | 0.900 | - | Mlig455_042836 {REF} {Length: 3004} {Pfam: IBR domain, a half RING-finger domain [PF01485.23, score=75.3]} {Human: ENSG00000146373, RNF217, ring finger protein 217, [Score=83.6, Expect=5e-16]} {Mouse: ENSMUSG00000063760, Rnf217, ring finger protein 217, [Score=83.2, Expect=4e-16]} {Dmel: FBgn0036082, CG12362, [Score=57.0, Expect=4e-08]} {Celegans: WBGene00020462, T12E12.1, Potential E3 ubiquitin-protein ligase ariadne-2, [Score=57.0, Expect=4e-08]} {Smed: dd_Smed_v6_7986_0_1, dd_Smed_v6_7986_0_1, [Score=61.2, Expect=1e-09]} {RNA1310_42946} {RNA815_24345} Mlig455_045854 {REF} {Length: 3004} {Pfam: IBR domain, a half RING-finger domain [PF01485.23, score=74.7]} {Human: ENSG00000146373, RNF217, ring finger protein 217, [Score=83.2, Expect=5e-16]} {Mouse: ENSMUSG00000063760, Rnf217, ring finger protein 217, [Score=83.2, Expect=4e-16]} {Dmel: FBgn0036082, CG12362, [Score=57.4, Expect=3e-08]} {Celegans: WBGene00020462, T12E12.1, Potential E3 ubiquitin-protein ligase ariadne-2, [Score=57.8, Expect=2e-08]} {Smed: dd_Smed_v6_7986_0_1, dd_Smed_v6_7986_0_1, [Score=61.2, Expect=1e-09]} {RNA1310_42946} {RNA815_24345} Mlig455_045870 {REF} {Length: 3004} {Pfam: IBR domain, a half RING-finger domain [PF01485.23, score=74.9]} {Human: ENSG00000146373, RNF217, ring finger protein 217, [Score=83.2, Expect=5e-16]} {Mouse: ENSMUSG00000063760, Rnf217, ring finger protein 217, [Score=83.2, Expect=4e-16]} {Dmel: FBgn0036082, CG12362, [Score=57.4, Expect=3e-08]} {Celegans: WBGene00020462, T12E12.1, Potential E3 ubiquitin-protein ligase ariadne-2, [Score=57.0, Expect=4e-08]} {Smed: dd_Smed_v6_7986_0_1, dd_Smed_v6_7986_0_1, [Score=61.2, Expect=1e-09]} {RNA1310_42946} {RNA815_24345} |
9. | MligTC455_18945 | 41 | 0.86 | Mlig455_031602 | Neo: - Age: - |
2.838 | - | - | 0.993 | 0.943 | 0.902 | - | Mlig455_031602 {REF} {Length: 914} {RNA1310_75361} {RNA815_24378} | |
10. | MligTC455_47780 | 214 | 4.46 | Mlig455_018842, Mlig455_018853 | Neo: - Age: - |
2.834 | - | - | 0.993 | 0.940 | 0.901 | - | Mlig455_018842 {REF} {Length: 500} {RNA1509_48336} {RNA1310_73351} {RNA815_41082} Mlig455_018853 {REF} {Length: 593} {RNA1509_48336} {RNA1310_73351, RNA1509_48336} {RNA1509_48336, RNA815_41082} |
|
11. | MligTC455_52629 | 472 | 9.83 | Mlig455_059435 | Neo: - Age: Down-Up-Up Region-specific R2: 6.775 Region-enriched R2: 6.727/0.00002 |
2.833 | - | - | 0.992 | 0.940 | 0.901 | - | Mlig455_059435 {REF} {Length: 726} {RNA1509_48505} {RNA1310_62885} {RNA815_39881} | |
12. | MligTC455_45351 | 241 | 5.02 | Mlig455_031191 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.622/0.00310 |
2.831 | - | - | 0.961 | 0.951 | 0.919 | - | Mlig455_031191 {REF} {Length: 2855} {Pfam: Srg family chemoreceptor [PF02118.23, score=28.1]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=26.4]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=26.4]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=49.3, Expect=2e-06]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [Score=54.7, Expect=4e-08]} {RNA1509_20184} {RNA1310_32455} {RNA815_38062} | |
13. | MligTC455_16476 | 126 | 2.63 | Mlig455_042936 | Neo: - Age: - Region-enriched R2: 3.045/0.04509 |
2.825 | - | - | 0.961 | 0.936 | 0.928 | - | Mlig455_042936 {REF} {Length: 2571} {Pfam: Innexin [PF00876.20, score=347.0]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=102, Expect=9e-24]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=280, Expect=3e-91]} {Smed: dd_Smed_v6_10567_0_1, dd_Smed_v6_10567_0_1, [RH, Score=498, Expect=8e-177]} {RNA1509_13614} {RNA1310_14284} {RNA815_5221} | |
14. | MligTC455_33440 | 62 | 1.29 | Mlig455_053806, Mlig455_053807 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.142/0.02950 |
GRID1 | 2.821 | - | - | 0.979 | 0.941 | 0.901 | - | Mlig455_053806 {REF} {Length: 3070} {Pfam: Ligand-gated ion channel [PF00060.28, score=72.9]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.7]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=39.8]; Receptor family ligand binding region [PF01094.30, score=28.6]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=145, Expect=2e-35]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=143, Expect=2e-34]} {Dmel: FBgn0038837, CG3822, [Score=126, Expect=2e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=112, Expect=3e-25]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=257, Expect=1e-77]} {RNA1310_13880.2} {RNA815_12458} Mlig455_053807 {REF} {Length: 3142} {Pfam: Ligand-gated ion channel [PF00060.28, score=79.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=38.3]; Receptor family ligand binding region [PF01094.30, score=36.5]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=139, Expect=2e-33]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=137, Expect=1e-32]} {Dmel: FBgn0038837, CG3822, [Score=125, Expect=5e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=117, Expect=1e-26]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=259, Expect=2e-78]} {RNA1310_13880.2} {RNA815_12458} |
15. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
2.816 | - | - | 0.962 | 0.928 | 0.926 | - | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
16. | MligTC455_49451 | 16 | 0.34 | Mlig455_030374 | Neo: - Age: - |
NOX5 | 2.808 | - | - | 0.969 | 0.939 | 0.900 | - | Mlig455_030374 {REF} {Length: 890} {Pfam: EF hand [PF00036.34, score=93.4]; EF-hand domain [PF13405.8, score=86.0]; EF hand [PF13202.8, score=73.1]; EF-hand domain pair [PF13499.8, score=70.3]; EF-hand domain pair [PF13833.8, score=49.3]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=29.0]; EF-hand domain [PF14658.8, score=23.2]; Caleosin related protein [PF05042.15, score=20.4]; EF-hand domain [PF17958.3, score=19.8]} {Human: ENSG00000255346, NOX5, NADPH oxidase 5, [Score=67.4, Expect=2e-13]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.5, Expect=3e-13]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=63.2, Expect=4e-13]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=63.2, Expect=4e-13]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=63.2, Expect=4e-13]} {Dmel: FBgn0033238, azot, ahuizotl, [Score=64.3, Expect=1e-13]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=62.4, Expect=6e-13]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=101, Expect=2e-28]} {RNA1310_74457} |
17. | MligTC455_18099 | 24 | 0.51 | Mlig455_036525 | Neo: - Age: - |
PPA1 | 2.806 | - | - | 0.974 | 0.929 | 0.903 | - | Mlig455_036525 {REF} {Length: 1911} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1310_57333.1} {RNA815_22340} |
18. | MligTC455_48713 | 380 | 7.92 | Mlig455_009259, Mlig455_009268 | Neo: - Age: Down-Up-Down Region-specific R2: 6.962 Region-enriched R2: 4.845/0.00046 |
2.804 | - | - | 0.982 | 0.947 | 0.875 | - | Mlig455_009259 {REF} {Length: 654} {RNA1509_35038} {RNA1310_72135} {RNA815_37404} Mlig455_009268 {REF} {Length: 546} {RNA1509_35038} {RNA1310_72135, RNA1509_35038} {RNA1509_35038, RNA815_37404} |
|
19. | MligTC455_22077 | 58 | 1.2 | Mlig455_041277 | Neo: - Age: - |
2.802 | - | - | 0.974 | 0.933 | 0.895 | - | Mlig455_041277 {REF} {Length: 1351} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=30.4]} {RNA1310_27422} {RNA815_33833} | |
20. | MligTC455_45021 | 381 | 7.95 | Mlig455_046686 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.428/0.03156 |
AVP | 2.796 | - | - | 0.957 | 0.909 | 0.930 | - | Mlig455_046686 {REF} {Length: 1388} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.2]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=54.3, Expect=2e-09]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=53.1, Expect=3e-09]} {RNA1509_50574} {RNA1310_38922} {RNA815_23813} |
21. | MligTC455_43714 | 152 | 3.18 | Mlig455_000684, Mlig455_000736 | Neo: - Age: - |
2.795 | - | - | 0.975 | 0.943 | 0.877 | - | Mlig455_000684 {REF} {Length: 796} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} Mlig455_000736 {REF} {Length: 797} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} |
|
22. | MligTC455_39463 | 228 | 4.76 | Mlig455_025914, Mlig455_025946 | Neo: - Age: - Regeneration-downregulated R4: -3.846 Regeneration-depleted R4: -3.846 |
2.793 | - | - | - | 0.945 | 0.883 | 0.965 | Mlig455_025914 {REF} {Length: 1257} {RNA1310_37139.1} {RNA815_50944} Mlig455_025946 {REF} {Length: 2808} {tRNA: Ala(CGC),pseudo, score=22.1} {Pfam: Lectin C-type domain [PF00059.23, score=35.2]} {Smed: dd_Smed_v6_84586_0_1, dd_Smed_v6_84586_0_1, [RH, Score=53.1, Expect=4e-09]} {RNA1509_4810} {RNA1310_37139.1} {RNA815_40603} |
|
23. | MligTC455_37200 | 32 | 0.67 | Mlig455_030215, Mlig455_030221, Mlig455_067995, Mlig455_067998 | Neo: - Age: - |
2.791 | - | - | 0.974 | 0.957 | - | 0.860 | Mlig455_030215 {REF} {Length: 1088} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=23.5]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=106, Expect=1e-25]} {RNA1310_102374} Mlig455_030221 {REF} {Length: 1980} {RNA1310_56149} {RNA815_31265} Mlig455_067995 {REF} {Length: 792} {Pfam: SAP domain [PF02037.29, score=35.7]} {RNA1509_8096} {RNA1310_1771} {RNA815_801} Mlig455_067998 {REF} {Length: 1295} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=24.0]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=105, Expect=2e-25]} {RNA1310_102374} |
|
24. | MligTC455_48714 | 132 | 2.74 | Mlig455_037041 | Neo: - Age: - Region-enriched R2: 4.531/0.00493 |
2.786 | - | - | 0.976 | 0.884 | 0.926 | - | Mlig455_037041 {REF} {Length: 1099} {RNA1509_35038} {RNA1310_72135} {RNA815_37404} | |
25. | MligTC455_16610 | 98 | 2.05 | Mlig455_069894 | Neo: - Age: - Region-enriched R2: 5.254/0.03136 |
WSCD2 | 2.785 | - | - | 0.976 | 0.938 | 0.871 | - | Mlig455_069894 {REF} {Length: 827} {Pfam: WSC domain [PF01822.21, score=59.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=55.1, Expect=4e-09]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=47.8, Expect=9e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=52.4, Expect=2e-08]} {RNA1509_46267} {RNA1310_46146} {RNA815_32275.1} |
26. | MligTC455_23314 | 139 | 2.9 | Mlig455_039680 | Neo: - Age: - |
CACNA2D2 | 2.784 | - | - | 0.935 | - | 0.896 | 0.953 | Mlig455_039680 {REF} {Length: 4498} {Pfam: VWA N-terminal [PF08399.13, score=89.9]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=86.3]; von Willebrand factor type A domain [PF13768.8, score=38.0]; von Willebrand factor type A domain [PF00092.30, score=36.1]; von Willebrand factor type A domain [PF13519.8, score=31.5]; Cache domain [PF02743.20, score=26.9]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [RH, Score=340, Expect=6e-98]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=328, Expect=3e-94]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [RH, Score=338, Expect=1e-97]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=330, Expect=4e-95]} {Dmel: FBgn0028863, CG4587, [RH, Score=234, Expect=2e-62]} {Celegans: WBGene00007041, tag-180, [RH, Score=169, Expect=3e-42]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=155, Expect=5e-38]} {RNA1509_48733} {RNA1310_3844, RNA1509_48733} {RNA1509_48733, RNA815_18071} |
27. | MligTC455_40388 | 23 | 0.47 | Mlig455_019615 | Neo: - Age: - |
2.781 | - | - | 0.921 | 0.953 | 0.907 | - | Mlig455_019615 {REF} {Length: 2102} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=34.2]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=144, Expect=9e-37]} {RNA1310_29891} {RNA815_15562} | |
28. | MligTC455_10966 | 15 | 0.31 | Mlig455_013154 | Neo: - Age: - |
2.776 | - | - | 0.950 | 0.919 | 0.907 | - | Mlig455_013154 {REF} {Length: 827} {Pfam: Lectin C-type domain [PF00059.23, score=21.8]} {RNA1509_20946} {RNA1310_65161} {RNA815_4785.1} | |
29. | MligTC455_29412 | 46 | 0.96 | Mlig455_000627, Mlig455_008268, Mlig455_040614 | Neo: - Age: Up-Down-Up |
2.77 | - | - | 0.959 | 0.934 | 0.877 | - | Mlig455_000627 {REF} {Length: 1331} {RNA1310_62571} {RNA815_30942} Mlig455_008268 {REF} {Length: 1779} {RNA1509_47298} {RNA1310_98344} {RNA815_10804.1} Mlig455_040614 {REF} {Length: 1016} |
|
30. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 2.769 | - | - | 0.905 | 0.954 | 0.910 | - | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |
31. | MligTC455_37286 | 90 | 1.88 | Mlig455_025470, Mlig455_071141 | Neo: - Age: - |
GRIA2 | 2.768 | - | - | 0.980 | 0.853 | 0.935 | - | Mlig455_025470 {REF} {Length: 3546} {Pfam: Ligand-gated ion channel [PF00060.28, score=83.8]; Receptor family ligand binding region [PF01094.30, score=50.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.9]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=120, Expect=2e-27]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=119, Expect=7e-27]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=118, Expect=2e-26]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=117, Expect=4e-26]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=116, Expect=6e-26]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=115, Expect=1e-25]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=115, Expect=2e-25]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=118, Expect=1e-26]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=118, Expect=9e-27]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=117, Expect=2e-26]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=116, Expect=4e-26]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=116, Expect=4e-26]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=115, Expect=6e-26]} {Dmel: FBgn0038837, CG3822, [Score=153, Expect=5e-38]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=112, Expect=3e-25]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=228, Expect=9e-67]} {RNA1310_33468} Mlig455_071141 {REF} {Length: 3783} {Pfam: Ligand-gated ion channel [PF00060.28, score=83.8]; Receptor family ligand binding region [PF01094.30, score=50.3]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.8]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=118, Expect=2e-26]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=118, Expect=2e-26]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=115, Expect=1e-25]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=115, Expect=2e-25]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=114, Expect=2e-25]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=113, Expect=5e-25]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=117, Expect=3e-26]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=117, Expect=1e-26]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=115, Expect=5e-26]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=115, Expect=6e-26]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=113, Expect=3e-25]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=112, Expect=6e-25]} {Dmel: FBgn0038837, CG3822, [Score=154, Expect=4e-38]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=112, Expect=3e-25]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=228, Expect=7e-67]} {RNA1310_33468} |
32. | MligTC455_46881 | 15 | 0.32 | Mlig455_061546 | Neo: - Age: Down-Up-Up |
IAH1 | 2.765 | - | - | 0.985 | 0.912 | 0.868 | - | Mlig455_061546 {REF} {Length: 1647} {Pfam: GDSL-like Lipase/Acylhydrolase family [PF13472.8, score=76.2]; GDSL-like Lipase/Acylhydrolase [PF00657.24, score=32.9]} {Human: ENSG00000134330, IAH1, isoamyl acetate hydrolyzing esterase 1 (putative), [Score=139, Expect=6e-40]} {Mouse: ENSMUSG00000062054, Iah1, isoamyl acetate-hydrolyzing esterase 1 homolog, [Score=122, Expect=1e-33]} {Smed: dd_Smed_v6_6241_0_1, dd_Smed_v6_6241_0_1, [Score=112, Expect=2e-30]} {RNA1310_108127} {RNA815_31492} |
33. | MligTC455_43173 | 392 | 8.16 | Mlig455_037383 | Neo: - Age: Up-Down-Down Regeneration-downregulated TP: -5.031 Regeneration-depleted TP: -5.031 |
C2orf16 | 2.764 | - | - | 0.961 | 0.943 | 0.860 | - | Mlig455_037383 {REF} {Length: 2450} {Pfam: Cornifin (SPRR) family [PF02389.17, score=23.4]} {Human: ENSG00000221843, C2orf16, chromosome 2 open reading frame 16, [Score=80.1, Expect=7e-15]} {RNA1509_52401} {RNA1310_14622.1} {RNA815_17994} |
34. | MligTC455_12512 | 80 | 1.68 | Mlig455_017689 | Neo: - Age: - |
2.762 | - | - | 0.954 | 0.920 | 0.888 | - | Mlig455_017689 {REF} {Length: 934} {RNA1310_37507} {RNA815_32171} | |
35. | MligTC455_30463 | 95 | 1.98 | Mlig455_000250, Mlig455_058521, Mlig455_058532 | Neo: - Age: - |
2.76 | - | - | 0.901 | 0.954 | 0.905 | - | Mlig455_000250 {REF} {Length: 1994} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.7]} {RNA1310_59451} {RNA815_40085} Mlig455_058521 {REF} {Length: 1237} {RNA1310_56656} {RNA815_40085} Mlig455_058532 {REF} {Length: 1973} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.5]} {RNA1310_59451} {RNA815_40085} |
|
36. | MligTC455_50844 | 224 | 4.67 | Mlig455_018511 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.591/0.00005 |
SSUH2 | 2.76 | - | - | 0.963 | 0.842 | 0.955 | - | Mlig455_018511 {REF} {Length: 1843} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=120, Expect=2e-29]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=95.5, Expect=3e-21]} {RNA1509_39980} {RNA1310_60742, RNA1509_39980} {RNA1509_39980, RNA815_28938} |
37. | MligTC455_17578 | 447 | 9.32 | Mlig455_010738 | Neo: - Age: Down-Up-Up Region-specific R2: 8.320 Region-enriched R2: 9.793/0.00000 |
2.754 | - | - | 0.977 | 0.935 | 0.842 | - | Mlig455_010738 {REF} {Length: 642} {RNA1509_48297, RNA1509_55742} {RNA1310_84623, RNA1509_48297, RNA1509_55742} {RNA1509_48297, RNA1509_55742, RNA815_45356} | |
38. | MligTC455_19079 | 218 | 4.54 | Mlig455_008746, Mlig455_008760 | Neo: - Age: Down-Up-Up Region-specific R2: 6.705 Region-enriched R2: 6.864/0.00152 |
2.746 | - | - | 0.954 | 0.937 | 0.855 | - | Mlig455_008746 {REF} {Length: 652} {RNA1310_75395.1} {RNA815_42524} Mlig455_008760 {REF} {Length: 1051} {RNA1310_75395.1} {RNA815_42524} |
|
39. | MligTC455_11109 | 30 | 0.62 | Mlig455_043718, Mlig455_043804 | Neo: - Age: Up-Down-Down |
2.736 | - | - | 0.970 | 0.924 | 0.842 | - | Mlig455_043718 {REF} {Length: 1591} {RNA1310_49834.1} {RNA815_39415} Mlig455_043804 {REF} {Length: 1594} {RNA1310_49834.2} {RNA815_39415} |
|
40. | MligTC455_40444 | 2996 | 62.42 | Mlig455_039527, Mlig455_051318 | Neo: - Age: Down-Up-Down |
2.735 | - | - | 0.929 | 0.976 | 0.830 | - | Mlig455_039527 {REF} {Length: 710} {RNA1509_7655} {RNA1310_63393} {RNA815_30324} Mlig455_051318 {REF} {Length: 721} {RNA1509_7655} {RNA1310_63393, RNA1509_7655} {RNA1509_7655, RNA815_30324} |
|
41. | MligTC455_43072 | 81 | 1.68 | Mlig455_042521 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.590/0.02161 |
2.733 | - | - | 0.956 | 0.955 | 0.822 | - | Mlig455_042521 {REF} {Length: 1049} {RNA1509_46101} {RNA1310_32444} {RNA815_30668} | |
42. | MligTC455_49434 | 157 | 3.26 | Mlig455_068252, Mlig455_068272 | Neo: - Age: - |
2.733 | - | - | 0.953 | 0.862 | 0.918 | - | Mlig455_068252 {REF} {Length: 718} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.5, Expect=1e-12]} {RNA1310_75052} Mlig455_068272 {REF} {Length: 1055} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.2, Expect=2e-12]} {RNA1310_75052} |
|
43. | MligTC455_10299 | 72 | 1.51 | Mlig455_023028, Mlig455_023125, Mlig455_023183 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.617 Region-enriched R2: 4.572/0.04281 |
ANGPTL1 | 2.73 | - | - | 0.977 | 0.870 | - | 0.883 | Mlig455_023028 {REF} {Length: 2538} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=130.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=115, Expect=8e-29]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=112, Expect=1e-27]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=114, Expect=2e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=112, Expect=9e-28]} {Dmel: FBgn0050280, CG30280, [Score=103, Expect=9e-26]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=50.8, Expect=4e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} Mlig455_023125 {REF} {Length: 2398} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=127.5]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=112, Expect=2e-27]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=107, Expect=1e-25]} {Mouse: ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=107, Expect=7e-26]} {Dmel: FBgn0050280, CG30280, [Score=92.8, Expect=6e-22]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=51.2, Expect=3e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} Mlig455_023183 {REF} {Length: 2190} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=115, Expect=2e-28]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=110, Expect=9e-27]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=113, Expect=4e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=110, Expect=6e-27]} {Dmel: FBgn0003326, sca, scabrous, [Score=104, Expect=8e-25]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=50.4, Expect=4e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} |
44. | MligTC455_32028 | 19 | 0.39 | Mlig455_019343, Mlig455_019346 | Neo: - Age: - |
GRIA2 | 2.728 | - | - | 0.990 | 0.949 | 0.789 | - | Mlig455_019343 {REF} {Length: 3241} {Pfam: Ligand-gated ion channel [PF00060.28, score=96.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=57.9]; Receptor family ligand binding region [PF01094.30, score=49.1]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=19.0]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=150, Expect=1e-36]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=149, Expect=2e-36]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=146, Expect=2e-35]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=144, Expect=9e-35]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=144, Expect=1e-34]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=150, Expect=5e-37]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=150, Expect=8e-37]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=145, Expect=3e-35]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=145, Expect=3e-35]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=144, Expect=5e-35]} {Dmel: FBgn0039927, CG11155, [Score=158, Expect=1e-39]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=125, Expect=3e-29]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=250, Expect=2e-75]} {RNA1509_10728} {RNA1310_4026} {RNA815_8415.1} Mlig455_019346 {REF} {Length: 519} {Pfam: Receptor family ligand binding region [PF01094.30, score=21.5]} {RNA1509_10728} {RNA1310_4026} {RNA815_8415.2} |
45. | MligTC455_46229 | 215 | 4.48 | Mlig455_022523, Mlig455_022563 | Neo: - Age: - Region-enriched R2: 5.024/0.00529 |
2.726 | - | - | 0.910 | 0.969 | 0.847 | - | Mlig455_022523 {REF} {Length: 2044} {RNA1310_42787} {RNA815_17352} Mlig455_022563 {REF} {Length: 1991} {RNA1310_42787} {RNA815_17352} |
|
46. | MligTC455_04855 | 16 | 0.34 | Mlig455_005010, Mlig455_005053, Mlig455_005260 | Neo: - Age: logFC(26M/2M)=0.904 |
HCRTR2 | 2.724 | - | - | 0.984 | 0.877 | 0.863 | - | Mlig455_005010 {REF} {Length: 1532} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=207, Expect=5e-61]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=209, Expect=7e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=8e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=4e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=7e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005053 {REF} {Length: 3639} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005260 {REF} {Length: 1614} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} |
47. | MligTC455_12511 | 68 | 1.42 | Mlig455_017662 | Neo: - Age: - |
2.719 | - | - | 0.967 | 0.845 | 0.907 | - | Mlig455_017662 {REF} {Length: 906} {RNA1310_37507} {RNA815_32171} | |
48. | MligTC455_48756 | 622 | 12.96 | Mlig455_054772, Mlig455_054799, Mlig455_054893 | Neo: - Age: - Region-specific R2: 7.873 Region-enriched R2: 9.003/0.00000 |
2.718 | - | - | 0.930 | 0.958 | 0.830 | - | Mlig455_054772 {REF} {Length: 716} {RNA1509_41507} {RNA1310_49516} {RNA815_28703} Mlig455_054799 {REF} {Length: 625} {RNA1509_41507} {RNA1310_49516} {RNA815_28703} Mlig455_054893 {REF} {Length: 947} {RNA1509_41507} {RNA1310_49516, RNA1509_41507} {RNA1509_41507, RNA815_28703} |
|
49. | MligTC455_21291 | 27 | 0.57 | Mlig455_009651 | Neo: - Age: - |
2.714 | - | - | 0.990 | 0.842 | 0.882 | - | Mlig455_009651 {REF} {Length: 3534} {RNA1310_43941} {RNA815_61115} | |
50. | MligTC455_12183 | 53 | 1.11 | Mlig455_004166, Mlig455_004190 | Neo: - Age: - Region-enriched R2: 4.930/0.01881 |
2.71 | - | - | 0.970 | 0.892 | 0.848 | - | Mlig455_004166 {REF} {Length: 2818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.4]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=29.1]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=8e-12]} {RNA1310_64973} {RNA815_58453} Mlig455_004190 {REF} {Length: 2742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=28.6]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=56.2, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=1e-11]} {RNA1310_62602} {RNA815_58453} |
|
51. | MligTC455_45020 | 386 | 8.05 | Mlig455_012422 | Neo: - Age: - Region-enriched R2: 4.067/0.00066 |
AVP | 2.71 | - | - | 0.957 | 0.908 | 0.845 | - | Mlig455_012422 {REF} {Length: 1252} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.0]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=50.4, Expect=4e-08]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=52.0, Expect=7e-09]} {RNA1509_50574} {RNA1310_26737, RNA1509_50574} {RNA1509_50574, RNA815_23813} |
52. | MligTC455_53720 | 144 | 2.99 | Mlig455_028516 | Neo: - Age: - Region-enriched R2: 4.205/0.01762 |
CTBP2 | 2.707 | - | - | 0.950 | 0.872 | 0.885 | - | Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484} |
53. | MligTC455_29100 | 53 | 1.11 | Mlig455_022386, Mlig455_022475 | Neo: - Age: - Region-enriched R2: 7.567/0.00114 |
KREMEN2 | 2.698 | - | - | 0.980 | 0.842 | 0.876 | - | Mlig455_022386 {REF} {Length: 4145} {tRNA: Val(CAC),pseudo, score=29.3} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=48.5, Expect=3e-06]; ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=47.0, Expect=7e-06]} {RNA1509_55375} {RNA1310_18706} {RNA815_23500} Mlig455_022475 {REF} {Length: 3047} {Pfam: WSC domain [PF01822.21, score=46.0]; PAN domain [PF00024.28, score=23.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=51.2, Expect=4e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=53.5, Expect=5e-08]} {RNA1509_47157} {RNA1310_35396.1} {RNA815_23500} |
54. | MligTC455_40617 | 11 | 0.22 | Mlig455_043552 | Neo: - Age: - |
WSCD2 | 2.698 | - | - | 0.972 | 0.842 | 0.884 | - | Mlig455_043552 {REF} {Length: 962} {Pfam: WSC domain [PF01822.21, score=54.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=57.8, Expect=3e-09]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=58.2, Expect=1e-09]} |
55. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
2.678 | - | - | 0.816 | 0.959 | 0.903 | - | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
56. | MligTC455_38875 | 37 | 0.78 | Mlig455_029375, Mlig455_029415 | Neo: - Age: logFC(26M/2M)=-0.939 |
GRIK2 | 2.677 | - | - | 0.977 | 0.928 | 0.772 | - | Mlig455_029375 {REF} {Length: 3713} {Pfam: Ligand-gated ion channel [PF00060.28, score=88.9]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=58.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=34.5]; Receptor family ligand binding region [PF01094.30, score=20.4]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=136, Expect=2e-32]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=137, Expect=9e-33]} {Dmel: FBgn0038837, CG3822, [Score=150, Expect=4e-37]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=126, Expect=1e-29]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=242, Expect=3e-72]} {RNA1310_67049} {RNA815_49856} Mlig455_029415 {REF} {Length: 2520} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=25.5]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=73.9, Expect=5e-14]} {RNA1310_74947} {RNA815_49856} |
57. | MligTC455_10082 | 430 | 8.96 | Mlig455_000403, Mlig455_000471 | Neo: - Age: - Region-enriched R2: 2.917/0.00040 |
2.673 | - | - | 0.951 | 0.920 | 0.802 | - | Mlig455_000403 {REF} {Length: 747} {RNA1310_48386} {RNA815_37422} Mlig455_000471 {REF} {Length: 750} {RNA1310_48386} {RNA815_37422} |
|
58. | MligTC455_10899 | 46 | 0.95 | Mlig455_013784, Mlig455_013915 | Neo: - Age: - |
2.673 | - | - | 0.985 | 0.888 | 0.800 | - | Mlig455_013784 {REF} {Length: 1362} {Pfam: Glycine rich protein [PF12810.9, score=20.8]} {RNA1509_28715} {RNA1310_91773} {RNA815_35307} Mlig455_013915 {REF} {Length: 1516} {Pfam: Glycine rich protein [PF12810.9, score=20.3]} {RNA1509_28715} {RNA1310_91773} {RNA815_35307} |
|
59. | MligTC455_34369 | 112 | 2.34 | Mlig455_015308, Mlig455_015354, Mlig455_036248, Mlig455_068737, Mlig455_070110 | Neo: - Age: Up-Down-Up Region-enriched R2: 5.462/0.00546 |
2.672 | - | - | 0.972 | 0.907 | 0.793 | - | Mlig455_015308 {REF} {Length: 1459} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.9]} {RNA1310_34740} {RNA815_15663} Mlig455_015354 {REF} {Length: 1446} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=66.3]; Sialidase, N-terminal domain [PF02973.18, score=18.5]} {RNA1310_34740} {RNA815_15663} Mlig455_036248 {REF} {Length: 2111} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=120.9]; Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=28.5]; PAN domain [PF00024.28, score=19.9]} {RNA1509_45496} {RNA1310_2539.1} {RNA815_252.1} Mlig455_068737 {REF} {Length: 1096} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=68.3]; Sialidase, N-terminal domain [PF02973.18, score=19.9]} {RNA1310_34740} {RNA815_37905} Mlig455_070110 {REF} {Length: 1340} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=109.6]} {RNA1509_32599} {RNA1310_1659} {RNA815_252.1} |
|
60. | MligTC455_17177 | 103 | 2.15 | Mlig455_048992, Mlig455_049009 | Neo: - Age: Down-Down-Up |
2.668 | - | - | 0.969 | 0.931 | 0.768 | - | Mlig455_048992 {REF} {Length: 1836} {RNA1509_44702} {RNA1310_14743, RNA1509_44702} {RNA1509_44702, RNA815_20669.1} Mlig455_049009 {REF} {Length: 1823} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} |
|
61. | MligTC455_05098 | 127 | 2.65 | Mlig455_009525, Mlig455_009531 | Neo: - Age: Up-Down-Down Region-enriched R4: 4.095/0.01821 |
KCNH7 | 2.662 | - | - | 0.974 | 0.897 | 0.791 | - | Mlig455_009525 {REF} {Length: 2109} {Pfam: Ion transport protein [PF00520.33, score=111.8]; Ion channel [PF07885.18, score=46.1]; Cyclic nucleotide-binding domain [PF00027.31, score=36.3]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=29.8]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=528, Expect=4e-176]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=509, Expect=2e-170]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=505, Expect=9e-167]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=527, Expect=4e-175]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=510, Expect=3e-171]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=504, Expect=9e-167]} {Dmel: FBgn0003353, sei, seizure, [Score=507, Expect=2e-171]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=496, Expect=1e-169]} {Smed: dd_Smed_v6_12978_0_1, dd_Smed_v6_12978_0_1, [Score=608, Expect=0.0]} {RNA1509_56964} {RNA1310_41939} {RNA815_5858.1} Mlig455_009531 {REF} {Length: 3631} {Pfam: Ion transport protein [PF00520.33, score=110.4]; Ion channel [PF07885.18, score=45.2]; Cyclic nucleotide-binding domain [PF00027.31, score=43.3]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=619, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=597, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=596, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=617, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=602, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=596, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [Score=591, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=579, Expect=0.0]} {Smed: dd_Smed_v6_12978_0_4, dd_Smed_v6_12978_0_4, [RH, Score=716, Expect=0.0]} {RNA1509_56964} {RNA1310_23186, RNA1509_56964} {RNA1509_56964, RNA815_5858.2} |
62. | MligTC455_40290 | 58 | 1.21 | Mlig455_058728 | Neo: - Age: - Region-enriched R2: 4.464/0.00807 |
2.659 | - | - | 0.967 | 0.842 | 0.850 | - | Mlig455_058728 {REF} {Length: 1351} {Pfam: CUB domain [PF00431.22, score=48.4]} {RNA1310_48745} {RNA815_23305} | |
63. | MligTC455_34810 | 109 | 2.27 | Mlig455_024348, Mlig455_024465 | Neo: - Age: - Region-enriched R2: 5.365/0.04615 |
2.658 | - | - | 0.802 | 0.954 | 0.902 | - | Mlig455_024348 {REF} {Length: 934} {RNA1310_67817} {RNA815_52313} Mlig455_024465 {REF} {Length: 1036} {RNA1310_67817} {RNA815_52313} |
|
64. | MligTC455_51178 | 190 | 3.97 | Mlig455_066114 | Neo: - Age: - |
2.655 | - | - | 0.981 | 0.732 | 0.942 | - | Mlig455_066114 {REF} {Length: 2408} {Smed: dd_Smed_v6_70006_0_1, dd_Smed_v6_70006_0_1, [Score=58.5, Expect=4e-10]} {RNA1509_36492} {RNA1310_14560, RNA1509_36492} {RNA1509_36492, RNA815_5366} | |
65. | MligTC455_46188 | 25 | 0.51 | Mlig455_039664, Mlig455_039727 | Neo: - Age: - |
2.643 | - | - | 0.988 | 0.845 | 0.810 | - | Mlig455_039664 {REF} {Length: 1353} Mlig455_039727 {REF} {Length: 1348} |
|
66. | MligTC455_10083 | 397 | 8.27 | Mlig455_000410, Mlig455_000477 | Neo: - Age: logFC(26M/2M)=1.533 Region-enriched R2: 3.033/0.00070 |
2.64 | - | - | 0.954 | 0.915 | 0.771 | - | Mlig455_000410 {REF} {Length: 1205} {RNA1509_50537} {RNA1310_48386} {RNA815_37422} Mlig455_000477 {REF} {Length: 1206} {RNA1509_50537} {RNA1310_48386} {RNA815_37422} |
|
67. | MligTC455_43963 | 1010 | 21.04 | Mlig455_015437 | Neo: - Age: Down-Down-Up Region-enriched R2: 2.083/0.01168 |
2.64 | - | - | 0.955 | 0.791 | 0.894 | - | Mlig455_015437 {REF} {Length: 612} {RNA1509_32160} {RNA1310_60746, RNA1509_32160} {RNA1509_32160, RNA815_30740} | |
68. | MligTC455_48064 | 23 | 0.48 | Mlig455_061550 | Neo: - Age: - |
2.637 | - | - | 0.967 | 0.917 | 0.753 | - | Mlig455_061550 {REF} {Length: 860} {RNA1310_88363} {RNA815_47885} | |
69. | MligTC455_31933 | 105 | 2.18 | Mlig455_062083 | Neo: - Age: - |
ANGPTL1 | 2.634 | - | - | 0.977 | 0.772 | 0.885 | - | Mlig455_062083 {REF} {Length: 1024} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=156.7]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=135, Expect=7e-36]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=132, Expect=2e-34]; ENSG00000101280, ANGPT4, angiopoietin 4, [Score=132, Expect=9e-35]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=137, Expect=1e-36]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=132, Expect=4e-35]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=131, Expect=1e-34]} {Dmel: FBgn0034160, CG5550, [Score=130, Expect=2e-36]} {Celegans: WBGene00020516, T15B7.1, [Score=73.9, Expect=9e-15]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=126, Expect=2e-32]} {RNA1509_14033} {RNA1310_32107.2} {RNA815_17173.3} |
70. | MligTC455_17218 | 37 | 0.78 | Mlig455_053853 | Neo: - Age: - |
2.631 | - | - | 0.871 | 0.954 | 0.806 | - | Mlig455_053853 {REF} {Length: 1743} {RNA1310_61921} | |
71. | MligTC455_33704 | 135 | 2.81 | Mlig455_002733 | Neo: - Age: Up-Down-Down |
COL5A2 | 2.628 | - | - | 0.937 | 0.967 | - | 0.724 | Mlig455_002733 {REF} {Length: 6615} {Pfam: Collagen triple helix repeat (20 copies) [PF01391.20, score=136.4]; Myotubularin protein [PF12335.10, score=23.9]} {Human: ENSG00000204262, COL5A2, collagen type V alpha 2 chain, [Score=113, Expect=6e-25]; ENSG00000049089, COL9A2, collagen type IX alpha 2 chain, [Score=111, Expect=1e-24]} {Mouse: ENSMUSG00000026147, Col9a1, collagen, type IX, alpha 1, [Score=124, Expect=2e-28]; ENSMUSG00000026042, Col5a2, collagen, type V, alpha 2, [Score=122, Expect=1e-27]; ENSMUSG00000041984, Rptn, repetin, [Score=121, Expect=1e-27]; ENSMUSG00000045672, Col27a1, collagen, type XXVII, alpha 1, [Score=120, Expect=3e-27]} {Dmel: FBgn0016075, vkg, viking, [Score=106, Expect=5e-23]} {Celegans: WBGene00000708, col-135, COLlagen, [Score=84.0, Expect=2e-16]} {Smed: dd_Smed_v6_8075_0_1, dd_Smed_v6_8075_0_1, [Score=140, Expect=9e-34]} {RNA1310_28728} {RNA815_22052} |
72. | MligTC455_38949 | 105 | 2.19 | Mlig455_065209 | Neo: - Age: - Region-specific R2: 7.633 Region-enriched R2: 10.088/0.00000 |
2.628 | - | - | 0.967 | 0.933 | 0.728 | - | Mlig455_065209 {REF} {Length: 591} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=23.2]} {RNA1509_44618} {RNA1310_63839, RNA1509_44618} {RNA1509_44618, RNA815_35329} | |
73. | MligTC455_22712 | 451 | 9.39 | Mlig455_036500, Mlig455_056387 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.479 Regeneration-upregulated BL: 3.623 Regeneration-enriched BL: 3.623 |
CASZ1 | 2.627 | - | - | 0.896 | - | 0.778 | 0.953 | Mlig455_036500 {REF} {Length: 3533} {Human: ENSG00000130940, CASZ1, castor zinc finger 1, [RH, Score=266, Expect=1e-73]} {Mouse: ENSMUSG00000028977, Casz1, castor zinc finger 1, [RH, Score=271, Expect=2e-75]} {Dmel: FBgn0004878, cas, castor, [RH, Score=267, Expect=3e-76]} {Smed: dd_Smed_v6_6778_0_1, dd_Smed_v6_6778_0_1, [RH, Score=478, Expect=1e-152]} {RNA1509_38584} {RNA1310_14915, RNA1509_38584} {RNA1509_38584, RNA815_45739} Mlig455_056387 {REF} {Length: 3535} {Human: ENSG00000130940, CASZ1, castor zinc finger 1, [Score=222, Expect=5e-60]} {Mouse: ENSMUSG00000028977, Casz1, castor zinc finger 1, [Score=223, Expect=2e-60]} {Dmel: FBgn0004878, cas, castor, [Score=219, Expect=4e-61]} {Smed: dd_Smed_v6_6778_0_1, dd_Smed_v6_6778_0_1, [Score=275, Expect=4e-79]} {RNA1509_38584} {RNA1310_14915} {RNA815_45739} |
74. | MligTC455_19708 | 304 | 6.32 | Mlig455_009784 | Neo: - Age: - Region-enriched R2: 6.355/0.00039 |
2.622 | - | - | 0.938 | 0.958 | 0.726 | - | Mlig455_009784 {REF} {Length: 826} {Pfam: Pancreatic hormone peptide [PF00159.20, score=43.3]} {RNA1509_54211} {RNA1310_54505.1, RNA1509_54211} {RNA1509_54211, RNA815_29389} | |
75. | MligTC455_13846 | 32 | 0.67 | Mlig455_013761 | Neo: - Age: - |
CALM2 | 2.604 | - | - | 0.747 | 0.950 | 0.907 | - | Mlig455_013761 {REF} {Length: 941} {Pfam: EF hand [PF00036.34, score=94.2]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13499.8, score=83.6]; EF hand [PF13202.8, score=77.1]; EF-hand domain pair [PF13833.8, score=42.5]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=31.3]; EF-hand domain [PF14658.8, score=23.8]; Ca2+ insensitive EF hand [PF08726.12, score=21.5]; Caleosin related protein [PF05042.15, score=21.3]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=60.1, Expect=1e-11]; ENSG00000160014, CALM3, calmodulin 3, [Score=60.1, Expect=1e-11]; ENSG00000198668, CALM1, calmodulin 1, [Score=60.1, Expect=1e-11]; ENSG00000178363, CALML3, calmodulin like 3, [Score=59.3, Expect=2e-11]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=60.5, Expect=1e-11]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=60.1, Expect=8e-12]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=60.1, Expect=8e-12]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=59.7, Expect=1e-11]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=60.8, Expect=3e-12]} {Celegans: WBGene00019352, K03A1.4, [Score=70.9, Expect=8e-16]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=97.4, Expect=1e-26]} {RNA1310_47452} {RNA815_31258} |
76. | MligTC455_38682 | 102 | 2.12 | Mlig455_039641 | Neo: - Age: - Region-enriched R2: 6.138/0.02363 |
SLC18A3 | 2.604 | - | - | 0.959 | 0.804 | 0.841 | - | Mlig455_039641 {REF} {Length: 3925} {Pfam: Major Facilitator Superfamily [PF07690.18, score=147.1]; Sugar (and other) transporter [PF00083.26, score=29.0]; LacY proton/sugar symporter [PF01306.21, score=20.2]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [RH, Score=469, Expect=9e-161]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [RH, Score=469, Expect=1e-160]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [RH, Score=513, Expect=2e-177]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [RH, Score=486, Expect=2e-167]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [RH, Score=563, Expect=0.0]} {RNA1310_28397} {RNA815_32284.1} |
77. | MligTC455_45063 | 105 | 2.19 | Mlig455_045829, Mlig455_045845, Mlig455_045862 | Neo: - Age: - |
2.604 | - | - | 0.982 | 0.880 | - | 0.742 | Mlig455_045829 {REF} {Length: 4186} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Celegans: WBGene00016064, acd-1, [Score=70.9, Expect=1e-12]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=120, Expect=1e-28]} {RNA1509_43949} {RNA1310_15301.1} {RNA815_26865} Mlig455_045845 {REF} {Length: 3433} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=149.9]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=61.2, Expect=1e-09]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [Score=101, Expect=1e-22]} {RNA1509_43949} {RNA1310_15301.1} {RNA815_26865} Mlig455_045862 {REF} {Length: 3524} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Celegans: WBGene00016064, acd-1, [Score=70.9, Expect=1e-12]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=120, Expect=1e-28]} {RNA1509_43949} {RNA1310_15301.1, RNA1509_43949} {RNA1509_43949, RNA815_26865} |
|
78. | MligTC455_43390 | 28 | 0.59 | Mlig455_064273 | Neo: - Age: Down-Up-Down |
PRKAR2A | 2.6 | - | - | 0.960 | 0.744 | 0.896 | - | Mlig455_064273 {REF} {Length: 2394} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.5]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=314, Expect=6e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=5e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628} |
79. | MligTC455_17806 | 20 | 0.42 | Mlig455_044877 | Neo: - Age: - |
2.554 | - | - | 0.962 | 0.850 | 0.742 | - | Mlig455_044877 {REF} {Length: 1723} {Pfam: F5/8 type C domain [PF00754.27, score=29.9]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [RH, Score=67.8, Expect=2e-14]} {RNA1310_72359} {RNA815_40265} | |
80. | MligTC455_17021 | 49 | 1.02 | Mlig455_030263 | Neo: - Age: - |
2.55 | - | - | 0.991 | 0.748 | 0.811 | - | Mlig455_030263 {REF} {Length: 566} {TRANSSPLICED} {Pfam: Galactosyltransferase [PF01762.23, score=23.7]} {Dmel: FBgn0000221, brn, brainiac, [Score=45.8, Expect=1e-06]} {RNA1310_35735} {RNA815_59866} | |
81. | MligTC455_28693 | 60 | 1.26 | Mlig455_022354 | Neo: - Age: - |
2.542 | - | - | 0.991 | 0.716 | 0.835 | - | Mlig455_022354 {REF} {Length: 816} {Pfam: WSC domain [PF01822.21, score=53.0]; PAN domain [PF00024.28, score=20.6]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=48.1, Expect=2e-06]} {RNA1509_43359} {RNA1310_59466.1} {RNA815_19988} | |
82. | MligTC455_19887 | 43 | 0.9 | Mlig455_012639, Mlig455_012658 | Neo: - Age: - |
AC243734.1 | 2.533 | - | - | 0.971 | 0.764 | 0.798 | - | Mlig455_012639 {REF} {Length: 2609} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=222.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=213.5]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=270, Expect=7e-83]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=270, Expect=7e-83]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=267, Expect=1e-81]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=271, Expect=2e-83]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=426, Expect=7e-143]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=317, Expect=8e-101]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=311, Expect=7e-99]} {RNA1509_48029} {RNA1310_34222.1} {RNA815_33884} Mlig455_012658 {REF} {Length: 2365} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=183.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=164.1]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=2e-115]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=2e-115]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=4e-116]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=360, Expect=2e-119]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=409, Expect=5e-138]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=335, Expect=5e-110]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=400, Expect=3e-135]} {RNA1509_48029} {RNA1310_34222.1} {RNA815_33884} |
83. | MligTC455_20390 | 87 | 1.82 | Mlig455_051716 | Neo: - Age: - |
SLC1A2 | 2.528 | - | - | 0.836 | 0.965 | 0.727 | - | Mlig455_051716 {REF} {Length: 4683} {Pfam: Sodium:dicarboxylate symporter family [PF00375.20, score=432.6]} {Human: ENSG00000110436, SLC1A2, solute carrier family 1 member 2, [RH, Score=530, Expect=0.0]} {Mouse: ENSMUSG00000005089, Slc1a2, solute carrier family 1 (glial high affinity glutamate transporter), member 2, [RH, Score=545, Expect=0.0]} {Dmel: FBgn0026439, Eaat1, Excitatory amino acid transporter 1, [RH, Score=375, Expect=4e-124]} {Celegans: WBGene00001620, glt-1, Excitatory amino acid transporter, [RH, Score=517, Expect=1e-179]} {Smed: dd_Smed_v6_7570_0_1, dd_Smed_v6_7570_0_1, [RH, Score=611, Expect=0.0]} {RNA1509_31315} {RNA1310_5180} {RNA815_8754} |
84. | MligTC455_34614 | 24 | 0.5 | Mlig455_060978 | Neo: - Age: - |
2.517 | - | - | 0.984 | 0.737 | 0.796 | - | Mlig455_060978 {REF} {Length: 1770} {RNA1310_81929} | |
85. | MligTC455_51537 | 225 | 4.69 | Mlig455_064569 | Neo: - Age: - |
2.517 | - | - | 0.967 | 0.780 | - | 0.770 | Mlig455_064569 {REF} {Length: 2141} {RNA1310_34295.1} {RNA815_22630} | |
86. | MligTC455_49417 | 47 | 0.97 | Mlig455_018820 | Neo: - Age: - |
2.49 | - | - | 0.975 | 0.785 | 0.730 | - | Mlig455_018820 {REF} {Length: 1221} {RNA1509_32397} {RNA1310_33051} {RNA815_37385} | |
87. | MligTC455_15212 | 12 | 0.26 | Mlig455_059838 | Neo: - Age: - |
ADRA2A | 2.485 | - | - | 0.977 | 0.700 | 0.808 | - | Mlig455_059838 {REF} {Length: 2182} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=239.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=36.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=28.6]; Olfactory receptor [PF13853.8, score=28.5]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=200, Expect=2e-57]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=198, Expect=1e-56]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=185, Expect=5e-51]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=195, Expect=5e-56]} {Smed: dd_Smed_v6_19063_0_1, dd_Smed_v6_19063_0_1, [Score=235, Expect=1e-71]} |
88. | MligTC455_35773 | 89 | 1.86 | Mlig455_064449, Mlig455_064456 | Neo: - Age: - Region-enriched R2: 5.198/0.00725 |
NANP | 2.482 | - | - | 0.976 | 0.715 | 0.791 | - | Mlig455_064449 {REF} {Length: 503} {NoTransDecoderORF} {RNA1310_53432.2} Mlig455_064456 {REF} {Length: 3122} {Pfam: Haloacid dehalogenase-like hydrolase [PF13419.8, score=56.3]; haloacid dehalogenase-like hydrolase [PF00702.28, score=55.3]; HAD-hyrolase-like [PF13242.8, score=44.6]} {Human: ENSG00000170191, NANP, N-acetylneuraminic acid phosphatase, [RH, Score=47.4, Expect=8e-06]} {Mouse: ENSMUSG00000053916, Nanp, N-acetylneuraminic acid phosphatase, [RH, Score=48.5, Expect=2e-06]} {Celegans: WBGene00018465, F45E1.4, [RH, Score=147, Expect=4e-43]} {Smed: dd_Smed_v6_2813_0_3, dd_Smed_v6_2813_0_3, [Score=174, Expect=2e-50]} {RNA1310_59243} {RNA815_62364} |
89. | MligTC455_52120 | 179 | 3.73 | Mlig455_024423, Mlig455_024577 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.068/0.01755 |
POU4F3 | 2.472 | - | - | 0.970 | 0.708 | 0.794 | - | Mlig455_024423 {REF} {Length: 1288} {TRANSSPLICED} {Pfam: Pou domain - N-terminal to homeobox domain [PF00157.19, score=104.8]; Homeodomain [PF00046.31, score=60.9]} {Human: ENSG00000091010, POU4F3, POU class 4 homeobox 3, [Score=212, Expect=1e-65]; ENSG00000152192, POU4F1, POU class 4 homeobox 1, [Score=211, Expect=2e-64]} {Mouse: ENSMUSG00000024497, Pou4f3, POU domain, class 4, transcription factor 3, [Score=212, Expect=7e-66]; ENSMUSG00000048349, Pou4f1, POU domain, class 4, transcription factor 1, [Score=211, Expect=2e-64]} {Dmel: FBgn0000028, acj6, abnormal chemosensory jump 6, [Score=209, Expect=2e-64]} {Celegans: WBGene00006818, unc-86, Transcription factor unc-86, [Score=188, Expect=4e-57]} {Smed: dd_Smed_v6_30562_0_1, dd_Smed_v6_30562_0_1, [Score=208, Expect=2e-64]} {RNA1509_57422} {RNA1310_23131} {RNA815_34447} Mlig455_024577 {REF} {Length: 1325} {TRANSSPLICED} {Pfam: Pou domain - N-terminal to homeobox domain [PF00157.19, score=104.8]; Homeodomain [PF00046.31, score=60.9]} {Human: ENSG00000091010, POU4F3, POU class 4 homeobox 3, [Score=212, Expect=1e-65]; ENSG00000152192, POU4F1, POU class 4 homeobox 1, [Score=211, Expect=2e-64]} {Mouse: ENSMUSG00000024497, Pou4f3, POU domain, class 4, transcription factor 3, [Score=212, Expect=7e-66]; ENSMUSG00000048349, Pou4f1, POU domain, class 4, transcription factor 1, [Score=211, Expect=2e-64]} {Dmel: FBgn0000028, acj6, abnormal chemosensory jump 6, [Score=209, Expect=2e-64]} {Celegans: WBGene00006818, unc-86, Transcription factor unc-86, [Score=188, Expect=4e-57]} {Smed: dd_Smed_v6_30562_0_1, dd_Smed_v6_30562_0_1, [Score=208, Expect=2e-64]} {RNA1509_57422} {RNA1310_23131} {RNA815_34447} |
90. | MligTC455_16248 | 132 | 2.74 | Mlig455_038325, Mlig455_050222, Mlig455_050231 | Neo: - Age: - |
CHRNA3 | 2.462 | - | - | 0.964 | 0.727 | 0.771 | - | Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042} Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042} Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042} |
91. | MligTC455_24753 | 11 | 0.23 | Mlig455_016700 | Neo: - Age: - |
2.454 | - | - | 0.988 | 0.712 | 0.754 | - | Mlig455_016700 {REF} {Length: 1032} {Pfam: PAN domain [PF00024.28, score=20.1]} {RNA1310_36328.1} {RNA815_39270} | |
92. | MligTC455_19775 | 36 | 0.74 | Mlig455_060359 | Neo: - Age: - |
FCN1 | 2.433 | - | - | 0.954 | 0.776 | 0.703 | - | Mlig455_060359 {REF} {Length: 1109} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.9]} {Human: ENSG00000085265, FCN1, ficolin 1, [Score=99.0, Expect=2e-23]; ENSG00000142748, FCN3, ficolin 3, [Score=99.0, Expect=1e-23]; ENSG00000160339, FCN2, ficolin 2, [Score=98.2, Expect=2e-23]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=100, Expect=3e-24]} {Dmel: FBgn0034160, CG5550, [Score=97.8, Expect=7e-24]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=90.1, Expect=4e-20]} {RNA1310_67383} {RNA815_45536} |
93. | MligTC455_37270 | 86 | 1.79 | Mlig455_022293 | Neo: - Age: - |
CASP3 | 2.399 | - | - | 0.960 | 0.736 | 0.703 | - | Mlig455_022293 {REF} {Length: 2773} {Pfam: Caspase domain [PF00656.24, score=93.1]; Ankyrin repeats (3 copies) [PF12796.9, score=77.8]; Ankyrin repeats (many copies) [PF13857.8, score=62.2]; Ankyrin repeats (many copies) [PF13637.8, score=56.0]; Ankyrin repeat [PF13606.8, score=39.1]; Ankyrin repeat [PF00023.32, score=28.2]} {Human: ENSG00000164305, CASP3, caspase 3, [Score=109, Expect=7e-26]; ENSG00000003400, CASP10, caspase 10, [Score=107, Expect=9e-24]; ENSG00000165806, CASP7, caspase 7, [Score=104, Expect=2e-23]} {Mouse: ENSMUSG00000025076, Casp7, caspase 7, [Score=106, Expect=9e-25]; ENSMUSG00000031628, Casp3, caspase 3, [Score=103, Expect=3e-24]} {Dmel: FBgn0010501, Dcp-1, Death caspase-1, [Score=96.3, Expect=3e-21]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=81.6, Expect=9e-17]} {Smed: dd_Smed_v6_3121_1_1, dd_Smed_v6_3121_1_1, [Score=102, Expect=3e-24]} {RNA1509_54818} {RNA1310_7187, RNA1509_54818} {RNA1509_54818, RNA815_8712} |
94. | MligTC455_48022 | 1337 | 27.86 | Mlig455_045267, Mlig455_069186 | Neo: - Age: - Region-enriched R2: 2.130/0.00146 |
2.399 | - | - | 0.962 | 0.719 | 0.718 | - | Mlig455_045267 {REF} {Length: 3628} {Pfam: Ankyrin repeats (many copies) [PF13857.8, score=29.5]; Ankyrin repeats (many copies) [PF13637.8, score=28.4]; Ankyrin repeats (3 copies) [PF12796.9, score=28.3]; Ankyrin repeat [PF13606.8, score=23.5]} {Celegans: WBGene00009375, F34D10.6, [Score=57.0, Expect=6e-08]} {Smed: dd_Smed_v6_5594_0_3, dd_Smed_v6_5594_0_3, [Score=58.5, Expect=1e-08]} {RNA1509_17412, RNA1509_32079} {RNA1310_5952, RNA1509_17412, RNA1509_32079} {RNA1509_17412, RNA1509_32079, RNA815_2323} Mlig455_069186 {REF} {Length: 3598} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=30.4]; Ankyrin repeats (3 copies) [PF12796.9, score=30.1]; Ankyrin repeats (many copies) [PF13857.8, score=29.5]; Ankyrin repeat [PF13606.8, score=24.1]} {Celegans: WBGene00009375, F34D10.6, [Score=56.6, Expect=6e-08]} {Smed: dd_Smed_v6_5594_0_4, dd_Smed_v6_5594_0_4, [Score=59.3, Expect=7e-09]} {RNA1509_52963} {RNA1310_5952, RNA1509_52963} {RNA1509_52963, RNA815_2323} |
|
95. | MligTC455_47712 | 80 | 1.66 | Mlig455_044833 | Neo: - Age: - |
1.972 | - | - | 0.995 | 0.977 | - | - | Mlig455_044833 {REF} {Length: 564} {RNA1509_55855} {RNA1310_87612} {RNA815_50831} | |
96. | MligTC455_50355 | 38 | 0.79 | Mlig455_057631 | Neo: - Age: - Region-enriched R2: 7.639/0.01837 |
1.946 | - | - | 0.991 | 0.955 | - | - | Mlig455_057631 {REF} {Length: 1003} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=47.4, Expect=6e-06]} {RNA1310_44307} {RNA815_33128} | |
97. | MligTC455_22088 | 35 | 0.73 | Mlig455_049477 | Neo: - Age: logFC(26M/2M)=-0.423 |
1.942 | - | - | 0.996 | - | - | 0.946 | Mlig455_049477 {REF} {Length: 3606} {TRANSSPLICED} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=109.4]; WSC domain [PF01822.21, score=26.7]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=55.5, Expect=2e-07]} {Smed: dd_Smed_v6_12037_0_1, dd_Smed_v6_12037_0_1, [Score=60.1, Expect=5e-09]} {RNA1509_30712} {RNA1310_3752.1} {RNA815_1359} | |
98. | MligTC455_42373 | 8 | 0.17 | Mlig455_008495 | Neo: - Age: - |
1.942 | - | - | 0.984 | 0.958 | - | - | Mlig455_008495 {REF} {Length: 3929} {RNA1310_106977} | |
99. | MligTC455_50253 | 44 | 0.92 | Mlig455_031495 | Neo: - Age: - |
GABRB2 | 1.937 | - | - | 0.980 | 0.957 | - | - | Mlig455_031495 {REF} {Length: 2129} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=58.3]} {Human: ENSG00000145864, GABRB2, gamma-aminobutyric acid type A receptor beta2 subunit, [Score=71.2, Expect=6e-14]} {Mouse: ENSMUSG00000007653, Gabrb2, gamma-aminobutyric acid (GABA) A receptor, subunit beta 2, [Score=67.8, Expect=1e-12]; ENSMUSG00000029212, Gabrb1, gamma-aminobutyric acid (GABA) A receptor, subunit beta 1, [Score=67.4, Expect=1e-12]} {Dmel: FBgn0024963, GluClalpha, [Score=54.3, Expect=3e-08]} {Celegans: WBGene00001594, glc-4, Glutamate-gated ChLoride channel, [Score=66.6, Expect=2e-12]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=70.1, Expect=9e-14]} {RNA1310_46931} {RNA815_25428} |
100. | MligTC455_11078 | 15 | 0.31 | Mlig455_045628 | Neo: - Age: - |
1.936 | - | - | 0.978 | 0.958 | - | - | Mlig455_045628 {REF} {Length: 2373} {Pfam: Polycystin cation channel [PF08016.14, score=25.4]} {RNA1310_39436.1} {RNA815_35444} |